Presbia, maker of the Flexiview Micro-Lens corneal implant, registers for an initial public offering worth up to $90 million.
Presbia, which makes the Flexiview Micro-Lens corneal implant to treat presbyopia, registered with the SEC for an initial public offering of up to $90 million worth of stock.
The Flexiview Micro-Lens is designed to be inserted into a pocket created in the cornea using a laser. The pocket seals itself, holding the 3mm-diameter lens in the center of the visual axis. The 10-minute procedure is reversible and does not require general anesthesia, according to Presbia's website.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1r4SEZs
Cap comentari:
Publica un comentari a l'entrada